Skip to main content

Advertisement

Table 2 Patient clinical characteristics

From: Long-term, up to 18 months, protective effects of the angiotensin II receptor blocker telmisartan on Epirubin-induced inflammation and oxidative stress assessed by serial strain rate

  TEL PLA
Patients evaluated 25 24
Male/female 6/19 6/18
Age, years: mean ± SD (range) 59 ± 14 (27–78) 52.9 ± 9 53 ± 10
Alive 23 21
Dead 2 3
Tumor type TEL PLA
Breast 8 10
Endometrium 12 9
Non-Hodgkin’s lymphoma 1 2
NSCLC 0 1
Ovary 4 1
Salivary gland 0 1
Stage TEL PLA
   I 14 13
   II 6 7
   III 4 3
   IV 1 1
ECOG/PS TEL PLA
  0 18 15
  1 6 4
  2 1 5
  1. Abbreviations. ECOG PS: Eastern Cooperative Oncology Group performance status; NSCLC: non-small cell lung cancer.